Indian manufacturer Brassica hit with warning letter after employees faked data results
The FDA has issued Indian CDMO Brassica Pharma a warning letter after inspectors found employees routinely falsified data records.
The regulator inspected Brassica’s facility in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.